facebook-page-view
Advertisement

Grapevine: KKR-controlled JB Chemicals eyes M&A; Lightrock partner on way out

By Sreeja Biswas

  • 11 Dec 2023
Premium
Grapevine: KKR-controlled JB Chemicals eyes M&A; Lightrock partner on way out
Credit: 123RF.com

Mumbai-based JB Chemicals & Pharmaceuticals Ltd, which is majority-owned by private equity firm KKR, is looking to acquire the Indian eyecare portfolio of drug major Novartis, a media report said.  Novartis is planning to sell the portfolio in a deal estimated to be around Rs 1,000 crore, The Times of India ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement